2014
DOI: 10.1002/ams2.57
|View full text |Cite
|
Sign up to set email alerts
|

Anti‐NMDAR encephalitis: case report and diagnostic issues

Abstract: Case: A 20-year-old woman developed acute psychotic symptoms and altered level of consciousness. She presented with neck stiffness, tremulous arms, facial dyskinesia, and distension of the lower abdomen. Pelvic magnetic resonance imaging showed bilateral ovarian teratomas. Anti-N-methyl-D-aspartate receptor antibodies were detected in her cerebrospinal fluid.Outcome: Resection of the tumors and immunotherapy were carried out. She gradually recovered and was discharged with few neurological deficits on the 105t… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2020
2020

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 10 publications
(12 reference statements)
0
2
0
Order By: Relevance
“…This includes corticosteroid therapy agents such as methylpredniso-lone, dexamethasone and prednisolone to reduce inflammation in the brain. Concurrent treatment with H2 receptor antagonists such as ranitidine or pantoprazole are given to prevent steroid induced mucosal damage (Omura et al, 2015). In addition, immunotherapies like intravenous immunoglobulin (IVIg) are administered to decrease inflammation of the meninges and inhibit the binding of anti-NMDA antibodies.…”
Section: Treatmentsmentioning
confidence: 99%
See 1 more Smart Citation
“…This includes corticosteroid therapy agents such as methylpredniso-lone, dexamethasone and prednisolone to reduce inflammation in the brain. Concurrent treatment with H2 receptor antagonists such as ranitidine or pantoprazole are given to prevent steroid induced mucosal damage (Omura et al, 2015). In addition, immunotherapies like intravenous immunoglobulin (IVIg) are administered to decrease inflammation of the meninges and inhibit the binding of anti-NMDA antibodies.…”
Section: Treatmentsmentioning
confidence: 99%
“…A notable clinical manifestation of anti-NMDA receptor encephalitis involves a triad of specific features that present as epilepsy, dyskinesia and psychiatric symptoms (Omura et al, 2015). A list of general clinical features such as focal neurological signs, psychiatric signs and autonomic instability noted in various documented cases to date are listed in the Table 1.…”
Section: Clinical Presentationmentioning
confidence: 99%